Precision Optics (POCI)
Search documents
Precision Optics Appoints Clay Schwabe as VP of Sales and Marketing
Newsfilter· 2024-07-08 13:00
GARDNER, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company's Vice President of Sales and Marketing. "We are extremely excited to welcome Clay Schwabe to the executive team at Precision Optics," stated Dr. Joe Forkey, CEO of Precision Optics. "Clay's entrepreneurial mindset and experience developin ...
Precision Optics Appoints Clay Schwabe as VP of Sales and Marketing
GlobeNewswire News Room· 2024-07-08 13:00
GARDNER, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company's Vice President of Sales and Marketing. Mr. Schwabe has over fifteen years of experience in medical device market access, sales, sales management, global product marketing, and commercialization. He is an emerging technologies specialist ...
Precision Optics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Newsfilter· 2024-05-23 13:00
GARDNER, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024. Company Webcast The webcasted presentation will ...
Precision Optics (POCI) - 2024 Q3 - Earnings Call Transcript
2024-05-16 00:58
With us on the call representing the company today are Dr. Joe Forkey, Precision Optics' Chief Executive Officer; and Mr. Wayne Coll, the company's Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session. With this validated ability to address the single-use part of the medical device market, combined with our many years of experience designing and producing reusable medical devices, our growing technical and production teams, our broad ...
Precision Optics (POCI) - 2024 Q3 - Quarterly Report
2024-05-15 20:16
or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-10647 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 PRECISION OPTICS CORPORATION, INC. (Exact name of registrant as specified in its charter) (State or other jurisdic ...
Precision Optics (POCI) - 2024 Q2 - Earnings Call Transcript
2024-02-15 03:16
Company Participants Conference Call Participants Operator Please note, this event is being recorded. I would now like to turn the conference over to Robert Blum of Lytham Partners. Please go ahead. All right. Thank you, Andrea, and to everyone as well for joining the call today. As the operator mentioned on today's call, we will discuss Precision Optics' second quarter fiscal year 2024 financial results for the period ended December 31, 2023. Today's conference call is also being webcast with replay capabi ...
Precision Optics (POCI) - 2024 Q2 - Quarterly Report
2024-02-14 21:16
Table of Contents Commission File Number: 001-10647 PRECISION OPTICS CORPORATION, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Exact name of registrant as specified in its charter) (State or other juris ...
Precision Optics (POCI) - 2024 Q1 - Quarterly Report
2023-11-14 21:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 For the transition period from to Commission File Number: 001-10647 PRECISION OPTICS CORPORATION, INC. (Exact name of registrant as specified in its charter) Massachusetts 04-2795294 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identific ...
Precision Optics (POCI) - 2024 Q1 - Earnings Call Transcript
2023-11-10 05:00
Hold on just a moment, Anthony. I believe we have perhaps one question just came in. Our next -- our question will come from [Norman Kadajian], a private investor. Precision Optics Corporation, Inc. (NASDAQ:POCI) Q1 2024 Results Conference Call November 9, 2023 5:00 PM ET Yes, sure. So the way I think about this is that this is really the long tail of COVID. And I know everyone's sick of hearing about COVID, but it still persists a little bit when it comes to some of the impacts on the business. The way we ...
Precision Optics (POCI) - 2023 Q4 - Earnings Call Transcript
2023-09-30 00:49
Robert Blum - Lytham Partners, LLC Joseph Forkey - President and Chief Executive Officer Wayne Coll - Chief Financial Officer I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead. Company Participants Operator Robert Blum With us on the call representing the company today are Dr. Joe Forkey, Precision Optics' President and Chief Executive Officer; and Wayne Coll, the company's Chief Financial Officer. At the conclusion of today's prepared remarks, we'll open the ...